Discover expert tips on maintaining bone health, including the role of innovative therapies like Osteoboost, in this Seattle Times feature.

The Mercury News highlights Osteoboost, a NASA-inspired wearable that reduces bone fracture risk through low-vibration therapy.

CEO Laura Yecies discusses Osteoboost, the FDA-cleared, drug-free wearable combating bone loss in postmenopausal women.

Orthopedics This Week reports on FDA clearance of Osteoboost, a wearable device using low-intensity vibrations to strengthen bones and prevent osteoporosis.

Medical Economics details Osteoboost's nationwide launch, an FDA-cleared wearable using vibration therapy to combat bone loss in spine and hips.

Femtech Insider reports on Osteoboost, the first FDA-cleared wearable device offering a non-drug solution for low bone density treatment.

San Francisco Business Times covers Osteoboost, a vibrating belt by Bone Health Technologies, aiding postmenopausal women in preserving bone density.

eMPR announces the availability of Osteoboost, an FDA-cleared wearable delivering targeted vibration therapy to strengthen bones in postmenopausal women.

ODTmag announces the U.S. launch of Osteoboost, an FDA-cleared wearable delivering targeted vibration therapy to strengthen bones in spine and hips.

Longevity.Technology reports on Osteoboost, an FDA-cleared wearable delivering at-home vibration therapy to combat bone loss in postmenopausal women.

Endocrine News spotlights the launch of Osteoboost, the first FDA-cleared wearable device offering a non-drug solution for low bone density.

Oprah Daily spotlights Osteoboost, an FDA-cleared wearable using NASA-inspired tech to combat bone loss in postmenopausal women.